| |
| |
|
| Insider
Information: |
Heinen Ernst |
| Relationship: |
Chief Development Offi... |
| City: |
Kansas City |
| State: |
KS |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aratana Therapeutics, Inc. |
PETX |
Chief Development Offi... |
2019-07-18 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2019-07-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(170,617) |
0 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
34,923 |
170,617 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2018-11-07 |
4 |
AS |
$6.95 |
$134,191 |
D/D |
(19,308) |
135,694 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2018-11-02 |
4 |
AS |
$6.95 |
$4,809 |
D/D |
(692) |
155,002 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2018-08-14 |
4 |
AS |
$5.15 |
$8,817 |
D/D |
(1,712) |
155,694 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2018-08-13 |
4 |
AS |
$5.15 |
$44,599 |
D/D |
(8,660) |
157,406 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2018-08-10 |
4 |
AS |
$5.15 |
$10,063 |
D/D |
(1,954) |
166,066 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2018-08-08 |
4 |
AS |
$5.15 |
$13,771 |
D/D |
(2,674) |
168,020 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2018-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
39,700 |
170,694 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2017-09-15 |
4 |
AS |
$6.25 |
$62,500 |
D/D |
(10,000) |
130,994 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2017-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
25,500 |
140,994 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2016-10-03 |
4 |
AS |
$10.00 |
$100,006 |
D/D |
(10,000) |
115,494 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2016-06-10 |
4 |
AS |
$6.72 |
$100,862 |
D/D |
(15,000) |
125,494 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2016-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
43,000 |
140,494 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2015-07-15 |
4 |
AS |
$17.06 |
$255,831 |
D/D |
(15,000) |
97,494 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2015-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,200 |
112,494 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Chief Development Officer |
• – – |
2014-05-05 |
4 |
AS |
$13.42 |
$134,200 |
D/D |
(10,000) |
95,294 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
SEE REMARKSOfficer |
• – – |
2013-06-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
105,294 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
